144 related articles for article (PubMed ID: 31982489)
1. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
[TBL] [Abstract][Full Text] [Related]
2. Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
Pitchakarn P; Ohnuma S; Pintha K; Pompimon W; Ambudkar SV; Limtrakul P
J Nutr Biochem; 2012 Jan; 23(1):76-84. PubMed ID: 21414769
[TBL] [Abstract][Full Text] [Related]
3. BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.
Yang Q; To KKW; Hu G; Fu K; Yang C; Zhu S; Pan C; Wang F; Luo K; Fu L
Cell Commun Signal; 2024 Jun; 22(1):325. PubMed ID: 38872211
[TBL] [Abstract][Full Text] [Related]
4. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS
Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301
[TBL] [Abstract][Full Text] [Related]
5. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
Aldonza MB; Hong JY; Bae SY; Song J; Kim WK; Oh J; Shin Y; Lee SH; Lee SK
PLoS One; 2015; 10(6):e0127841. PubMed ID: 26098947
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles.
Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H
Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
Tsuruo T; Naito M; Tomida A; Fujita N; Mashima T; Sakamoto H; Haga N
Cancer Sci; 2003 Jan; 94(1):15-21. PubMed ID: 12708468
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E reverses multidrug resistance in vitro and in vivo.
Tang J; Fu Q; Wang Y; Racette K; Wang D; Liu F
Cancer Lett; 2013 Aug; 336(1):149-57. PubMed ID: 23624302
[TBL] [Abstract][Full Text] [Related]
9. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer.
Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV
Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424
[TBL] [Abstract][Full Text] [Related]
10. T7 peptide-mediated co-delivery platform overcoming multidrug-resistant breast cancer: In vitro and in vivo evaluation.
Zhang SS; Yu JH; Jiang SS; Wang L; Chen J; Long J; Gu SX; Li H
Eur J Pharm Biopharm; 2024 Jul; 200():114327. PubMed ID: 38759900
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line.
Liu W; Zhang X; Sunakawa H; Perera LMB; Martha L; Mizoi K; Ogihara T
J Pharm Sci; 2024 Jun; 113(6):1674-1681. PubMed ID: 38432625
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.
Mahgoub TM; Jordan EJ; Mahdi AF; Oettl V; Huefner S; O'Donovan N; Crown J; Collins DM
Cancer Chemother Pharmacol; 2024 May; 93(5):427-437. PubMed ID: 38226983
[TBL] [Abstract][Full Text] [Related]
13. Zosuquidar: An Effective Molecule for Intracellular Ca
Pelegrinova L; Sofrankova L; Spaldova J; Stefik P; Sulova Z; Breier A; Elefantova K
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542082
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.
Hall MD; Brimacombe KR; Varonka MS; Pluchino KM; Monda JK; Li J; Walsh MJ; Boxer MB; Warren TH; Fales HM; Gottesman MM
J Med Chem; 2011 Aug; 54(16):5878-89. PubMed ID: 21721528
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells.
Li QQ; Wang WJ; Xu JD; Cao XX; Chen Q; Yang JM; Xu ZD
Cancer Sci; 2007 Nov; 98(11):1767-74. PubMed ID: 17725804
[TBL] [Abstract][Full Text] [Related]
16. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Amiri-Kordestani L; Basseville A; Kurdziel K; Fojo AT; Bates SE
Drug Resist Updat; 2012; 15(1-2):50-61. PubMed ID: 22464282
[TBL] [Abstract][Full Text] [Related]
17. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel.
Li QQ; Cao XX; Xu JD; Chen Q; Wang WJ; Tang F; Chen ZQ; Liu XP; Xu ZD
Cell Mol Life Sci; 2009 Feb; 66(3):504-15. PubMed ID: 19099191
[TBL] [Abstract][Full Text] [Related]
18. Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells.
Wang Q; Huang CH; Wibowo FS; Amin R; Shen J; Li F; Babu RJ
ACS Appl Mater Interfaces; 2024 Mar; 16(11):13509-13524. PubMed ID: 38466024
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide reverts multidrug resistance in KBCh
Lakra DS; Bharathiraja P; Dhanalakshmi T; Prasad NR
Cell Biochem Funct; 2024 Mar; 42(2):e3948. PubMed ID: 38379216
[TBL] [Abstract][Full Text] [Related]
20. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells.
Levchenko A; Mehta BM; Niu X; Kang G; Villafania L; Way D; Polycarpe D; Sadelain M; Larson SM
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1933-8. PubMed ID: 15671173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
